Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.

Clinical trial NCT06529562 · RECRUITING

Trial details

NCT number: NCT06529562
Sponsor: Ming-Yuan Chen
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2022-11-01
Primary completion: 2032-11-01
Enrollment: 384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.